Medtronic (NYSE:MDT) is touting positive results from a study of its InterStim sacral nerve stimulator for treating less-severe overactive bladder syndrome, saying the device produces "superior efficacy and quality of life" compared with medication alone.
Women's Health
Reducing C-section births: MindChild Medical gets FDA win for fetal heart monitor
MindChild Medical received 510(k) clearance from the U.S. FDA for a new fetal heart monitor the company says can detect tiny fluctuations in fetal heartbeats and potentially reduce the number of Caesarean sections pregnant women undergo.
Company officials said the regulatory win clears the way for the company to commercialize its Meridian non-invasive fetal heart monitor.
Hologic loses $4M patent suit to Smith & Nephew over Interlace fibroid tech
FDA grants Zynex 510(k) clearance for female incontinence device
Colorado-based device maker Zynex (OTC:ZYXI) won FDA clearance for its InWave device, an electrotherapy system for treating female urinary incontinence.
The company’s hoping that the InWave device will complement its existing electrotherapy portfolio and spur a boost in revenue, CEO Thomas Sandgaard said in a press release.
Women vs. men: Gender-based research at ESC 2012
FDA, Guided Therapeutics unveil plan for rejected LuViva cervical scanner PMA
Guided Therapeutics (OTC:GTHP) made new progress on its once-rejected pre-market approval bid for the LuViva advanced cervical cancer scanning system, which the FDA knocked with a "not approvable" letter in January.
MassDevice.com +3 | The top 3 med-tech stories for July 24, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Legal: Bard loses 1st of transvaginal mesh patient injury lawsuits
MassDevice.com +3 | The top 3 med-tech stories for June 27, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Mayo Clinic: Mammogram rates dropped after controversial federal recommendation
Mammogram rates decreased following controversial U.S. Preventative Services Task Force guidance that women under the age of 50 may not need routine screening, researchers found.
A Mayo Clinic team noted a 6% decline nationwide in mammograms for women in their 40s in the year after USPSTF revised its breast cancer screening guidance, a "small but significant decrease," researchers said.
MassDevice.com +3 | The top 3 med-tech stories for June 26, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.